Global artificial intelligence (AI) in oncology market is anticipated to grow at a CAGR of 32.6 % during the forecast period. Medical imaging analysis using AI is used to analyze medical images including X-rays, CT scans, MRIs, PET scans, and histopathology slides. It can help detect and characterize tumors, lesions, and abnormalities, in addition to identifying cancerous cells and tissue patterns. AI can additionally be used to analyze genomic data and determine how a patient’s genetic makeup affects their response to specific cancer drugs. Furthermore, AI can be used to create precise radiation therapy treatment plans, tailor chemotherapy regimens, identify the most suitable targeted therapies, and match cancer patients with suitable clinical trials. The market’s growth is attributed to data quality and accessibility. Utilizing electronic health records (EHRs) and platforms such as Vista, a significant amount of real-world, high-quality patient data can be collected. For developing insights into cancer treatment and training AI models, a comprehensive dataset is essential. For instance, in October 2023, COTA launched a new real-world data platform to accelerate cancer research and advance generative AI models in oncology. To promote real-world evidence (RWE) insights in oncology and to open the door for the development of trusted generative AI in cancer care, Vista was developed employing automation to speed up and, consequently, scale up EHR data abstraction.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/intelligence-ai-in-oncology-market
Furthermore, AI platforms such as Tara make use of a wide range of data sources, including electronic health records and genomic information. This has contributed to the increased importance of real-world data and real-world evidence in cancer research and treatment. in September 2023, Belong.Life launched Tara – an AI SaaS matching cancer patient to clinical trials. The Tara platform, aimed toward medical professionals and contract research organizations (CROs), was designed to accelerate the process of matching individuals with clinical trials that are appropriate for individuals.
Global Artificial Intelligence (AI) in Oncology Market Report Segment
By Component
- Software
- Hardware
- Services
By Cancer Type
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Brain Tumor
- Others (Pancreatic Cancer, and Ovarian Cancer)
By Treatment Type
- Chemotherapy and Drug Development
- Radiation Therapy
- Immunotherapy
- Others (Surgery, and Targeted Therapies)
A full report of Artificial Intelligence (AI) In Oncology Market available @ https://www.omrglobal.com/industry-reports/intelligence-ai-in-oncology-market
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Amazon Web Service, Inc.
- Azra AI.
- ai
- Clinithink
- ConcertAI LLC
- Exscientia plc
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
